Fernando M. S.
- Country
- Spain
- Department
- Intensive Care
Research Overview
Data & Insights
Has run more than one trial at 16 of 86 partner sites.
Specializations
Thoracic and solid tumor oncology
Fernando Martínez Sagasti is involved in clinical research across a broad range of advanced cancers, with particular emphasis on non-small cell lung cancer, small cell lung cancer, and other solid tumors. His trial portfolio also includes malignancies of the head and neck, gastrointestinal tract, ovary, bladder, and sarcoma.
- Non-small cell lung cancer
- Head and neck squamous cell carcinoma
- Advanced colorectal cancer
- Metastatic urothelial carcinoma
- Soft tissue sarcoma
His activity spans both locally advanced and metastatic disease settings, reflecting sustained interest in oncologic innovation for difficult-to-treat tumors.
Breast and gynecologic cancer
His research landscape includes multiple studies in breast cancer, especially hormone receptor-positive, HER2-negative, HER2-positive, and triple-negative breast cancer. He is also involved in trials addressing ovarian cancer, endometrial cancer, cervical cancer, and related gynecologic malignancies.
- Hormone receptor-positive breast cancer
- Triple-negative breast cancer
- Metastatic breast cancer
- Ovarian cancer
- Endometrial cancer
These studies place him in therapeutic areas focused on targeted treatment, adjuvant therapy, and disease control in recurrent or advanced disease.
Genitourinary oncology
Fernando Martínez Sagasti is active in clinical trials for renal cell carcinoma, urothelial carcinoma, and prostate cancer, covering both metastatic and locally advanced disease. His involvement also extends to muscle-invasive bladder cancer and upper tract urothelial carcinoma.
- Renal cell carcinoma
- Urothelial carcinoma
- Prostate cancer
- Muscle-invasive bladder cancer
- Upper tract urothelial carcinoma
This area of work reflects a strong therapeutic focus on urologic malignancies and advanced disease management.
Cardiovascular and metabolic disease
His clinical research includes atherosclerotic cardiovascular disease, heart failure, myocardial infarction, stroke, hypertension, and atrial fibrillation. Additional interests include obesity, lipid disorders, and prevention of major cardiovascular events.
- Atherosclerotic cardiovascular disease
- Heart failure
- Acute coronary syndrome
- Ischemic stroke
- Resistant hypertension
His portfolio also includes studies in cardiovascular risk reduction and complications linked to chronic cardiometabolic disease.
Neurology, immunology, and respiratory medicine
His trial activity further covers multiple sclerosis, epilepsy, Alzheimer’s disease, migraine, schizophrenia, and myasthenia gravis. In parallel, he is involved in studies of asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, systemic lupus erythematosus, and other immune-mediated disorders.
- Multiple sclerosis
- Epilepsy
- Alzheimer’s disease
- Myasthenia gravis
- Systemic lupus erythematosus
These domains show engagement with neurologic, autoimmune, and respiratory therapeutic development across chronic and acute conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.